AbbVie, Voyager Collaborate for Vectorized AD Antibodies
The collaboration intends to combine AbbVie’s clinical resources in monoclonal antibody develop with Voyager’s gene therapy platform.
Stem Cell Therapy Reverses Opioid Tolerance Effects
Mesenchymal stem cell transplantation showed long-lasting and consistent effects on opioid tolerance and opioid-induced hyperalgesia in rat and mouse models.
AMD Stem Cell Therapy Shows Potential for Vision Gain
The retinal injection therapy could be capable of replacing damaged cells integral to eye vision.
Gene Therapy Recovers LCA Patient Vision
Luxturna, an injection therapy, helped genetic vision-loss patients navigate mazes in a phase 3 trial.
FDA Committee Backs Gene Therapy Candidate
An advisory committee gave unanimous support to Luxturna, 3 months prior to its BLA ruling.
Type 1 Diabetes Cell Therapy Study Shows Promise in Pediatrics
The Sanford Project: T-Rex Study has reached its midway point through a Phase II, fast-tracked trial.